March 01, 2024
On February 3, the Zhang Family of Traditional Chinese Medicine (Traditional Chinese Medicine Oncology) Inheritance Essence, Integrity and Innovation Outstanding Contribution Award Ceremony, the strategic cooperation signing ceremony of Professor Tan Jingwang, an expert from the Chinese People’s Liberation Army General Hospital, and the opening ceremony of Professor Tan Jingwang’s studio were held at Jiaozuo Zhonghai Traditional Chinese Medicine The Cancer Hospital was held grandly.
Zhang Fenglou, former Vice Minister of Health and President of the China Health Supervision Association, and Xue Huiqing, a second-level researcher of the Jiaozuo Municipal Health Commission, delivered speeches respectively. Fan Tianyun, a second-level researcher from the Wuzhi County People's Government, presided over the ceremony. The directors of various township health centers in Wuzhi County and the heirs of the Zhang family of traditional Chinese medicine witnessed this important moment together.
Zhang Fenglou pointed out: The ultimate destination of inheritance is innovation. Innovation is also the profound foundation for the development of traditional Chinese medicine hospitals. We must inherit, carry forward and make good use of the precious heritage passed down by our ancestors. The Zhang family of traditional Chinese medicine has a history of more than 350 years. Mr. Zhang Zhonghai enjoys a high reputation and is widely recognized in the field of traditional Chinese medicine for cancer treatment. The development of traditional Chinese medicine requires inheritors like Zhang Zhonghai. Jiaozuo Zhonghai Traditional Chinese Medicine Cancer Hospital, a second-level hospital founded on the basis of the Zhang family of traditional Chinese medicine, has broad development prospects. In the future, it can also closely integrate traditional Chinese medicine treatment with late-stage cancer care to make traditional Chinese medicine cancer treatment bigger and stronger. Minimally non-invasive green therapy for tumors. It is reported that Professor Tan Jingwang is a doctor of traditional Chinese medicine and a postdoctoral fellow of western medicine. He serves as the director of the Department of Hepatobiliary and Pancreatic Surgery, Minimally Invasive Surgery, and Oncology Surgery at the Chinese People’s Liberation Army General Hospital (301 Hospital). He teamed up with nearly a hundred experts and scholars to form an "Intelligent Non-Invasive Medical Innovation Team" and pioneered the "minimally non-invasive integrated medical model" for malignant tumors that is well-known at home and abroad. Medicine) theory and practice system. Participated in a number of provincial and ministerial level major scientific and technological research projects on advanced tumors, liver transplantation, etc.
The Food and Drug Safety Education Working Committee of the China Medical Education Association, which awarded the Zhang Family of Traditional Chinese Medicine (TCM Oncology) Outstanding Contribution Award for Inheritance, Integrity and Innovation, has extensive influence in the domestic and foreign academic circles.
Figure 1: Award Ceremony of the Zhang Family of Traditional Chinese Medicine (TCM Oncology) Inheritance Essence, Integrity, Innovation and Outstanding Contribution Award
Figure 2: Strategic cooperation signing ceremony by expert Professor Tan Jingwang from the Chinese People’s Liberation Army General Hospital and the opening ceremony of Professor Tan Jingwang’s studio
Figure 3: Zhang Fenglou, former Vice Minister of Health and President of China Health Supervision Association, delivering a speech
